Other Scholarly Content

 

Inhibiting the Receptor Tyrosine Kinase-like Orphan Receptor 2 (ROR2) enzymewith small molecules for the treatment of cancer Public Deposited

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/defaults/ns064b897

Descriptions

Attribute NameValues
Creator
Abstract
  • Based on recent findings, our hypothesis is that the inhibition of the Receptor tyrosine kinase-like orphan receptor 2 (ROR2) enzyme can lead to tumor suppression. ROR2 are trans-membrane proteins that are part of the receptor tyrosine kinase (RTK) family. ROR2 is generally not expressed in most normal adult tissues and represents a new target in the WNT signaling pathway. In order to test our hypothesis, we have developed a model using transiently transfected HEK-293T cells to screen for inhibition of ROR2-mediated downstream signaling. The inhibition of ROR2 activation, through canonical WNT pathway, will be studied by monitoring the level of activated-ROR2-induced phosphorylation of G-protein coupledreceptor Kinase 2 (GRK2) compared to untreated cells. The research proposed is significant because it will lead to novel lead compounds for multiple tumor types.
Resource Type
Date Available
Date Issued
Degree Level
Degree Name
Advisor
Academic Affiliation
Non-Academic Affiliation
Rights Statement
Publisher
Peer Reviewed
Language
Replaces

Relationships

Parents:

This work has no parents.

In Collection:

Items